Recruiting NA Multiple Sclerosis (MS)

New treatment option for Multiple Sclerosis (MS)

Official title Increasing Physical Activity for Adults With Multiple Sclerosis (MS)

ClinicalTrials.gov ID: NCT06270641

What this study is testing

What it's testing
This study aims to advance the scientific understanding and potential future implementation of physical activity promotion by testing the efficacy of a phone-based app for increasing activity in insufficiently active patients with multiple sclerosis (MS).

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older. Healthy volunteers may be eligible.

You may be able to join if

  • Provider-confirmed diagnosis of MS using revised 2017 McDonald criteria
  • \> 18+ years of age
  • Patient determined disease steps (PDDS) score \< 3, indicating the potential for some gait disability although typically ambulates without an...
  • Insufficiently active, defined as \< 150 minutes of physical activity per week, assessed using the PAVS in the EHR in clinics as part of the routine...
  • Use of an iPhone with software version iOS13+ or an Android phone 4.1+

You likely can't join if

  • Recent (past 4 weeks) or planned surgery during the study period which may impact engaging in step counts
  • MS relapse within the last 30 days
  • Plans to travel internationally during the study period, which could interfere with server uploads of mobile phone data
  • Those at a higher risk of falling or injury from falls or unable to safely exercise due to other medical conditions (e.g. heart conditions, diabetes...
See the full eligibility criteria
Who can join
  • Provider-confirmed diagnosis of MS using revised 2017 McDonald criteria
  • \> 18+ years of age
  • Patient determined disease steps (PDDS) score \< 3, indicating the potential for some gait disability although typically ambulates without an assistive device
  • Insufficiently active, defined as \< 150 minutes of physical activity per week, assessed using the PAVS in the EHR in clinics as part of the routine patient intake process
  • Use of an iPhone with software version iOS13+ or an Android phone 4.1+
  • Agree to install and use the ExerciseRx app for the entire study period and keep their phone on them during the daytime (e.g., pocket, bags, hands)
What rules you out
  • Recent (past 4 weeks) or planned surgery during the study period which may impact engaging in step counts
  • MS relapse within the last 30 days
  • Plans to travel internationally during the study period, which could interfere with server uploads of mobile phone data
  • Those at a higher risk of falling or injury from falls or unable to safely exercise due to other medical conditions (e.g. heart conditions, diabetes or conditions made worse by walking or physical activity)

The study team makes the final eligibility decision.

Where it's taking place

  • Seattle, Washington, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Seattle, Washington, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.